Rapid clinical improvement at TransBarrier® in Boca Raton, Florida more than 5 years after a stroke.

Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Rapid clinical improvement at TransBarrier® in Boca Raton, Florida, three years after a stroke. The patient flew from England to TransBarrier® in Boca Raton, Florida to receive treatment. Rapid improvement in motor function and fine motor movements of the involved hand was documented, as well as rapid reduction in chronic central post-stroke pain.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Rapid neurological recovery beginning within minutes, 1.5 years after stroke in a patient from New Zealand. The patient’s wife describes improvement in walking ability, language abilities, sensation, vision, hearing, taste, etc. Video made at TransBarrier® in Los Angeles on June 9, 2014. Treatment with a single dose was on June 2, 2014.

6 July 2014

Dave and Brenda’s story has made the news in New Zealand. The story is published in the Otago Daily Times:

Rising to the challenge of a stroke
By Eileen Goodwin on Sun, 6 Jul 2014

“A Dunedin man thought to be the first New Zealander to undergo innovative stroke treatment in the United States believes it has improved his speech and walking, while reducing fatigue and pain….”

To read the entire story, please click here.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Neurological changes after stroke following treatment at TransBarrier® in Boca Raton. Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Two families, one from Queensland, Australia and the other from Invercargill, New Zealand, discuss their spouses improvements following treatment within the past week at TransBarrier® in Boca Raton, 5 years and 3 years after stroke, respectively. Begins with husband discussing his wife Katie’s improvements following treatment, and the reduced caregiver burden. Please be advised that individual results vary and some patients do not respond to treatment.

Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery byTransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A new scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Filmed at TransBarrier® in Los Angeles on September 3, 2014 and September 11, 2014.

16 months after stroke. Present in the video is the patient, from Adelaide, Australia; her son; and the patient’s carer. Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

Nearly 4 years after stroke, wife and her husband traveled from Gibraltar, Iberian Peninsula toTransBarrier® Boca Raton in Florida in October 2014. Chronic neurological dysfunction produced by stroke and traumatic brain injury has long been thought to be irreversible. A scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

November 14, 2014: 16 months after stroke, immediate neurological improvement beginning within minutes of treatment at TransBarrier® in Boca Raton, Florida. Patient accompanied by her two daughters. Improvements noted in chronic post-stroke pain; chronic post-stroke aphasia; taste (right side of tongue); brain “fog”; and walking.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.

More than 5 years after his stroke, a husband and wife travel from Sydney, Australia toTransBarrier® in Boca Raton, Florida for treatment.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label.  Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.